| |
Group's Investments
|
|
|
|
| |
|
|
Aeterna Zentaris Development of medication to fight cancer and other diseases |
|
17% |
|
SGF Solidarity Fund QFL, Other |
Axcan Pharma Inc. Development and production of prescription products in the field of gastroenterology |
|
N/A |
|
SGF TPG Capital Other |
|
Atrium Innovations Production and distribution of dietary supplements and health products |
|
6% |
|
SGF Aeterna Laboratories inc. Solidarity Fund QFL Private Investor Fonds d’investissement bioalimentaire |
GeneChem Thérapeutiques Venture capital fund specialized in research projects and companies involved in genomics |
|
7% |
|
SGF Fonds Bombardier, Shire Pharmaceutical, Solidarity Fund QFL |
MédiaMed Technologies Innovative technological solutions and consulting services used by hospitals and health care and social services centres. |
|
30% |
|
SGF |
| Medicago
Manufacturing of recombinant proteins for pharmaceutical use |
|
4% |
|
SGF Other |
Paladin Labs Inc. Acquiring or in-licensing innovative pharmaceutical products for the Canadian market |
|
N/A |
|
SGF Public |
|
Warnex Specialized analytical, bioanalytical and medical laboratory services |
|
25% |
|
SGF Public |
|
|
|
|